在美银证券全球研究部门将其评级从“中性”上调至“买入”后，Apellis Pharmaceuticals Inc. (APLS) 股价于盘前交易时段上涨3.7%。此次评级上调反映了市场对该制药公司前景的积极预期。
在美银证券全球研究部门将其评级从“中性”上调至“买入”后，Apellis Pharmaceuticals Inc. (APLS) 股价于盘前交易时段上涨3.7%。此次评级上调反映了市场对该制药公司前景的积极预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.